LENSAR, Inc.

NasdaqCM LNSR

LENSAR, Inc. Price to Sales Ratio (P/S) on January 14, 2025: 1.82

LENSAR, Inc. Price to Sales Ratio (P/S) is 1.82 on January 14, 2025, a 72.35% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

LENSAR, Inc. 52-week high Price to Sales Ratio (P/S) is 2.16 on December 31, 2024, which is 18.91% above the current Price to Sales Ratio (P/S).
LENSAR, Inc. 52-week low Price to Sales Ratio (P/S) is 0.76 on April 29, 2024, which is -58.35% below the current Price to Sales Ratio (P/S).
LENSAR, Inc. average Price to Sales Ratio (P/S) for the last 52 weeks is 1.24.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

NasdaqCM: LNSR

LENSAR, Inc.

CEO	Mr. Nicholas T. Curtis
IPO Date	Oct. 2, 2020
Location	United States
Headquarters	2800 Discovery Drive
Employees	130
Sector	Consumer Discretionary
Industries Eyewear Augmented Reality (AR) Cosmetics

Description

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.

Key trends

Past 5 years